Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,486 papers from all fields of science
Search
Sign In
Create Free Account
ChIP-exo
ChIP-exo is a chromatin immunoprecipitation based method for mapping the locations at which a protein of interest (transcription factor) binds to the…
Expand
Wikipedia
(opens in a new tab)
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Bioinformatics
ChIP-on-chip
Protein–DNA interaction
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Determination of data analysis pipeline for detection of Thap-9 binding sites in human genome
Vasudha Sharma
,
S. Majumdar
2017
Corpus ID: 90873835
Transposons are ubiquitously expressed DNA sequences that can move from one position within the genome to another, resulting in…
Expand
2016
2016
Understanding Molecular Mechanisms of Gene Regulationusing High Resolution ChIP-exo
Rohit Reja
2016
Corpus ID: 90411025
2016
2016
Computational Analysis Tool for Comprehensive in vivo Transcription Factor Binding Studies in ChIP-exo and ChIP-Nexus Experiments
T. Hartonen
2016
Corpus ID: 89458495
2015
2015
CexoR: an R/Bioconductor package to uncover high-resolution protein-DNA interactions in ChIP-exo replicates
Pedro Madrigal
2015
Corpus ID: 55511821
For its unprecedented level of spatial resolution, chromatin immunoprecipitation combined with λ exonuclease digestion followed…
Expand
2015
2015
ATF 4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW 3-56 in Triple-Negative Breast Cancer Cells
Shuwang
,
XiangyunAmyChen
,
+8 authors
Yanming Wang
2015
Corpus ID: 19999707
We previously reported that a pan-PAD inhibitor, YW3-56, activates p53 target genes to inhibit cancer growth. However, the p53…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE